

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
I-Bevacizumab-awwb iyikhambi lomdlavuza eliyi-biosimilar elisiza ukwelapha izinhlobo ezithile zomdlavuza ngokuvimba ukukhula kwemithambo yegazi emithanjeni. Kuyi-antibody eyenziwe e-laboratory elingisa amaprotheni omzimba wakho wokuzivikela emzimbeni, aklanyelwe ukubulala amaseli omdlavuza ngomsoco owadingayo ukuze akhule futhi asabalale.
Lo muthi ungowodidi lwemithi ebizwa ngokuthi ama-angiogenesis inhibitors, okusho ukuthi imisa imithombo yegazi emisha ekwakhiweni. Cabanga ngayo njengokusika imigqa yokuhlinzeka ngomsoco okhulisa amaseli omdlavuza, okwenza kube nzima ngawo ukusinda nokuzala emzimbeni wakho.
I-Bevacizumab-awwb iyisihlobo se-biosimilar somuthi wokuqala we-bevacizumab. I-Biosimilar empeleni iyikhophi efana kakhulu yomuthi osemthethweni obhaliwe osebenza ngendlela efanayo nomuthi wokuqala.
Lo muthi yi-monoclonal antibody, okusho ukuthi yakhelwe ukuhlasela iprotheni elilodwa emzimbeni wakho. Kulokhu, ihlasela iprotheni ebizwa ngokuthi i-VEGF (vascular endothelial growth factor) esetshenziswa amaseli omdlavuza ukwakha imithambo yegazi emisha.
Uzothola lo muthi ngokufakwa ngomthambo (IV), okusho ukuthi ungena ngqo emjondolo wakho wegazi ngomthambo. Ingxenye ethi "awwb" yegama imane nje isiza ukuhlukanisa le biosimilar ethile kwezinye izinhlobo.
I-Bevacizumab-awwb iphatha izinhlobo eziningi zomdlavuza othuthukile noma ometastatic. Udokotela wakho ngokuvamile uzoyibhala lapho umdlavuza usabalale kwezinye izingxenye zomzimba wakho noma lapho ezinye izindlela zokwelapha zingasebenzi ngokwanele.
Lo muthi uvame ukusetshenziselwa umdlavuza we-colorectal, ikakhulukazi lapho usabalale kwamanye amalunga omzimba. Ivame ukuhlanganiswa nemithi ye-chemotherapy ukuze yenze ukwelashwa okuphelele kuphumelele ekulweni nomdlavuza.
Eminye iminyango yomdlavuza engase iphathwe ngale mithi ihlanganisa izinhlobo ezithile zomdlavuza wamaphaphu, umdlavuza wezinso, nomdlavuza womlomo wesibeletho. Udokotela wakho we-oncologist uzoqoka ukuthi le mithi ilungele yini uhlobo lwakho oluthile nesigaba somdlavuza.
Ngezinye izikhathi odokotela basebenzisa i-bevacizumab-awwb ye-glioblastoma ebuyayo, uhlobo lomdlavuza wobuchopho oluqinile. Kulezi zimo, kungasiza ukunciphisa ukukhula kwesimila lapho ezinye izindlela zokwelapha ziyekile ukusebenza.
I-Bevacizumab-awwb isebenza ngokuvimba iphrotheni ebizwa nge-VEGF esetshenziswa amaseli omdlavuza ukukhulisa imithambo yegazi emisha. Uma amaseli omdlavuza engakwazi ukudala le mithambo yegazi emisha, aqala ukuthola umoya-mpilo kanye nezakhamzimba abazidingayo ukuze basinde futhi baphindaphane.
Lokhu kuthathwa njengokwelashwa okuqondiwe kunokwelashwa ngamakhemikhali okwesintu. Esikhundleni sokuhlasela wonke amaseli ahlukanisa ngokushesha, iqondisa ngqo indlela esiza izimila ukukhulisa ukuhlinzekwa kwegazi lazo.
Umuthi awubulali amaseli omdlavuza ngokuqondile njengoba kwenza ezinye izindlela zokwelapha. Kunalokho, uwaqeda ngokuqeda impilo yawo, okwenza abe sengozini enkulu kwezinye izindlela zokwelapha umdlavuza ongase uzithole.
Le ndlela ingasiza ukunciphisa ukukhula kwesimila futhi ingenza i-chemotherapy isebenze kahle uma isetshenziswa ndawonye. Noma kunjalo, ithathwa njengokwelashwa okusekelayo kunokwelapha ngayo yodwa.
Uzothola i-bevacizumab-awwb njenge-infusion ye-intravenous esibhedlela noma esikhungweni sokwelashwa komdlavuza. Umuthi kufanele unikezwe ochwepheshe bezempilo abaqeqeshiwe abangakuqapha ngesikhathi sokwelashwa.
Ukufakwa kwakho kokuqala ngokuvamile kuzothatha imizuzu engaba ngu-90, okuvumela ithimba lakho lezokwelapha ukuthi liqaphele ngokucophelela noma yiziphi izindlela. Uma ukubekezelela kahle umthamo wokuqala, ukufakwa kwesikhathi esizayo kungase kunikezwe ngemizuzu engama-60, futhi ekugcineni ngemizuzu engama-30.
Umuthi uvame ukunikezwa njalo ngemva kwamasonto angu-2-3, kuye ngohlelo lwakho oluqondile lokwelashwa kanye neminye imithi oyitholayo. Udokotela wakho we-oncologist uzochaza uhlelo oluqondile ngokusekelwe ohlotsheni lomdlavuza wakho kanye nempilo yakho yonke.
Akudingeki ukuthi uzile noma ulandele noma yikuphi ukudla okukhethekile ngaphambi kokufakwa komuthi. Nokho, kubalulekile ukuhlala unamanzi kahle futhi udle ngokujwayelekile ngaphandle uma udokotela wakho ekunikeza imiyalelo ehlukile.
Ubude bokwelashwa nge-bevacizumab-awwb buhlukahluka kakhulu kuye ngohlobo lomdlavuza wakho, ukuthi usabela kahle kangakanani ekwelashweni, nokuthi uyawuthwala kahle kangakanani umuthi. Abanye abantu bayawuthola izinyanga eziningana, kanti abanye bangase badinge ukuthi bawuthole unyaka wonke.
Udokotela wakho we-oncologist uzoqapha njalo umdlavuza wakho ngokuskena kanye nokuhlolwa kwegazi ukuze abone ukuthi ukwelashwa kusebenza kahle kangakanani. Uma umdlavuza wakho usabela kahle futhi ungaqali ukuba nemiphumela emibi, ukwelashwa kungase kuqhubeke.
Ukwelashwa kuvame ukuyeka uma umdlavuza wakho uqhubeka ngaphandle komuthi, uma uqala ukuba nemiphumela emibi, noma uma udokotela wakho enquma ukuthi izingozi zidlula izinzuzo. Ngezinye izikhathi ukwelashwa kungase kumiswe okwesikhashana uma udinga ukuhlinzwa noma uqala ukuba nezinkinga ezithile.
Isinqumo sokuqhubeka noma ukuyeka ukwelashwa ngaso sonke isikhathi senziwa ngokubambisana phakathi kwakho nethimba lakho le-oncology, kucatshangelwa impilo yakho yonke, izinga lempilo, kanye nemigomo yokwelashwa.
I-Bevacizumab-awwb ingabangela imiphumela ehlukahlukene, kusukela kokulula kuya kokubi. Abantu abaningi bathola eminye imiphumela emibi, kodwa eminingi iyaphathwa ngokunakekelwa okufanele kwezokwelapha nokuqapha.
Nawa amanye imiphumela emibi ejwayelekile ongase uyithole ngesikhathi sokwelashwa:
Le miphumela evamile ngokuvamile iyalawuleka, futhi ithimba lakho lezempilo lingakunikeza imithi noma amasu okukusiza ukuthi uzizwe ukhululekile.
Kukhona nemiphumela emibi ethile engavamile kodwa ebucayi edinga ukunakekelwa kwezempilo ngokushesha. Nakuba lokhu kungenzeki kuwo wonke umuntu, kubalulekile ukuyazi:
Ithimba lakho lezokwelapha lizokuhlola ngokusondele ukuze lithole le miphumela emibi futhi lizokufundisa ukuthi yiziphi izimpawu zokuxwayisa okufanele uzibheke ekhaya.
Ezinye iziphumela ezingavamile kodwa ezibucayi zihlanganisa i-reversible posterior leukoencephalopathy syndrome (RPLS), ethinta ubuchopho, kanye nokusabela okukhulu komzimba ngesikhathi sokufakwa. Lokhu akuvamile kodwa kudinga ukunakekelwa kwezempilo ngokushesha uma kwenzeka.
I-Bevacizumab-awwb ayifanele wonke umuntu, futhi udokotela wakho uzohlola ngokucophelela ukuthi iphephile yini kuwe. Izimo zezokwelapha ezithile noma izimo zenza le mithi ibe yingozi kakhulu ukuyisebenzisa.
Akufanele uthole lo muthi uma ukhulelwe noma uncelisa, ngoba ungalimaza ingane yakho esakhula. Abesifazane abaneminyaka yokuzala badinga ukusebenzisa izindlela zokuvimbela inzalo ezisebenzayo ngesikhathi sokwelashwa kanye nasezinyangeni ezimbalwa ngemuva komthamo wokugcina.
Abantu abahlinzwe muva nje noma abazohlinzwa kungenzeka abafaneleki kulokhu kwelashwa. Umuthi ungangena endleleni yokuphola kwamanxeba, ngakho udokotela wakho ngokuvamile uzolinda kuze kube yilapho usuphole ngokuphelele emsebenzini wokuhlinzwa ngaphambi kokuqala ukwelashwa.
Nawa amanye amanye amakhambi angakuvimbela ukuthi ungatholi i-bevacizumab-awwb:
Udokotela wakho we-oncologist uzobuyekeza umlando wakho wezokwelapha ophelele kanye nesimo sakho sempilo yamanje ukuze anqume ukuthi lokhu kwelashwa kulungele yini wena.
I-Bevacizumab-awwb itholakala ngaphansi kwegama lomkhiqizo elithi Mvasi. Le biosimilar yathuthukiswa ukuhlinzeka ngenketho eshibhile uma iqhathaniswa nomuthi wokuqala we-bevacizumab.
I-bevacizumab yasekuqaleni ithengiswa ngaphansi kwegama lomkhiqizo elithi Avastin. Yomibili imithi isebenza ngendlela efanayo futhi inokusebenza kahle okufanayo kanye namaphrofayili okuphepha.
Umshwalense wakho noma isikhungo sokwelashwa singanquma ukuthi iyiphi inguqulo oyitholayo. Zombili zithathwa njengezisebenza kahle ngokulinganayo ekwelapheni umdlavuza, ngakho-ke ungaqiniseka kunoma iyiphi inketho udokotela wakho ayincomayo.
Kukhona ezinye izindlela zokwelapha eziningana zomdlavuza i-bevacizumab-awwb ewulaphayo. Udokotela wakho we-oncologist uzocabangela lezi zinketho ngokusekelwe ohlotsheni lwakho oluthile lomdlavuza, isigaba, kanye nempilo yonke.
Ezinye izinto ezivimbela i-angiogenesis zihlanganisa i-ramucirumab kanye ne-aflibercept, ezisebenza ngendlela efanayo ngokuvimba ukukhula kwemithambo yegazi emithanjeni. Le mithi ingaba yizinketho uma i-bevacizumab-awwb ingakulungele noma iyeka ukusebenza.
Ukwelashwa okuhloswe ngakho njenge-cetuximab noma i-panitumumab kungaba ezinye izindlela zokwelapha izinhlobo ezithile zomdlavuza we-colorectal, ikakhulukazi uma umdlavuza wakho unezici ezithile zofuzo. Lokhu kusebenza ngendlela ehlukile ngokuhlosela amaprotheni ebusweni beseli lomdlavuza.
Izindlela zokwelapha ngamakhemikhali zendabuko zihlala ziyizinketho ezibalulekile zokwelapha futhi zivame ukusetshenziswa ngokuhlangana noma esikhundleni se-bevacizumab-awwb. Udokotela wakho we-oncologist uzosiza ekunqumeni indlela engcono kakhulu yokwelapha isimo sakho.
I-Bevacizumab-awwb (Mvasi) ne-Avastin zilingana ngemithi enempumelelo efanayo kanye nephrofayili yokuphepha. Umehluko omkhulu ukuthi i-bevacizumab-awwb iyi-biosimilar, evame ukubiza ngaphansi komuthi wokuqala.
Izifundo zomtholampilo zikhombisile ukuthi imithi ye-biosimilar efana ne-bevacizumab-awwb isebenza kahle njengozakwabo bokuqala. I-FDA idinga ama-biosimilars ukuthi ahlangabezane nezindinganiso eziqinile ezibonisa ukuthi zifana kakhulu nomuthi wokuqala.
Udokotela wakho angakhetha enye ngaphezu kwenye ngokusekelwe ezintweni ezinjengentengo, umshwalense, noma ukutholakala esikhungweni sakho sokwelapha. Yomibili imithi izokunikeza izinzuzo ezifanayo zokulwa nomdlavuza.
Ukukhetha phakathi kwabo kuvame ukwehla ezintweni ezingokoqobo kunokwelapha, ngoba zombili zithathwa njengezisebenza ngempumelelo futhi ziphephile ekwelapheni umdlavuza.
Abantu abanezifo zenhliziyo badinga ukucatshangelwa okukhethekile ngaphambi kokuqala i-bevacizumab-awwb. Umuthi ungakhuphula umfutho wegazi futhi ungase uqhubekisele phambili izinkinga zenhliziyo, ngakho-ke udokotela wakho we-oncologist uzosebenza eduze nodokotela wakho wenhliziyo ukunquma ukuthi kuphephile yini kuwe.
Uma unomlando wokuhluleka kwenhliziyo, ukuhlaselwa yinhliziyo kwakamuva, noma isifo senhliziyo esibi, udokotela wakho angase akhethe ezinye izindlela zokwelapha. Kodwa-ke, abantu abanezimo zenhliziyo ezithambile basengakwazi ukuthola umuthi ngokuqapha ngokucophelela.
Ithimba lakho lezokwelapha cishe lizobheka ukusebenza kwenhliziyo yakho ngokuqhubekayo ngesikhathi sokwelashwa, okuhlanganisa ukuhlolwa komfutho wegazi njalo futhi mhlawumbe nokuhlolwa kokusebenza kwenhliziyo. Bangase futhi balungise imithi yakho yenhliziyo noma umthamo we-bevacizumab-awwb uma kudingeka.
Njengoba i-bevacizumab-awwb inikezwa ochwepheshe bezempilo endaweni yezokwelapha, ukweqisa ngengozi akuvamile kakhulu. Umuthi ubhalwa ngokucophelela ngokuya ngesisindo sakho kanye nesimo sezokwelapha, futhi abasebenzi abaqeqeshiwe baqapha yonke inqubo yokufaka umuthi.
Uma ukhathazekile ngomthamo wakho noma uqaphela noma yiziphi izimpawu ezingavamile ngesikhathi noma ngemuva kokufakwa komuthi wakho, tshela ithimba lakho lezempilo ngokushesha. Bangahlola isimo sakho futhi banikeze ukunakekelwa okufanele uma kudingeka.
Abasebenzi bezokwelapha abaphatha ukwelashwa kwakho baqeqeshwe ukubhekana nanoma yiziphi izinkinga ezingase zivele. Banezinhlelo ezikhona zokuphatha noma yiziphi izindlela ezingezinhle noma izinkinga zokulinganisa ezingase zenzeke.
Uma uphuthelwa i-aphoyintimenti ehleliwe yokufakwa komuthi wakho we-bevacizumab-awwb, xhumana nethimba lakho le-oncology ngokushesha ngangokunokwenzeka ukuze uhlele kabusha. Bazosebenza nawe ukuze ubuyele emgqeni ngohlelo lwakho lokwelashwa.
Ukuphuthelwa umthamo owodwa ngokuvamile akuyingozi, kodwa kubalulekile ukugcina isimiso sakho sokwelashwa ukuze uthole imiphumela engcono kakhulu yokulwa nomdlavuza. Udokotela wakho angase alungise isikhathi sokuqokwa kwakho okulandelayo ngokuya ngesikhathi esidlulile.
Ungazami ukulungisa umthamo ophuthelwe ngokuthola imithi eyengeziwe. Ithimba lakho le-oncology lizothola indlela engcono kakhulu yokuqhubeka nohlelo lwakho lokwelashwa ngokuphepha nangempumelelo.
Isinqumo sokuyeka i-bevacizumab-awwb kufanele senziwe ngaso sonke isikhathi nodokotela wakho we-oncologist. Ukwelashwa kuvamile ukuqhubeka uma nje umdlavuza wakho uphendula kahle futhi ungaqali ukuba nemiphumela emibi kakhulu.
Udokotela wakho uzohlola njalo ukwelashwa kwakho ngokuskena, ukuhlolwa kwegazi, nokuhlolwa komzimba. Uma umdlavuza wakho uqhubeka ngaphandle kokwelashwa, noma uma imiphumela emibi iba mibi kakhulu, bangase bancomise ukuyeka imithi.
Abanye abantu bangase badinge ukuyeka okwesikhashana ukuze bathole ukuhlinzwa noma ukuphatha imiphumela emibi, bese beqhubeka nokwelashwa kamuva. Abanye bangase baqede inkambo yokwelashwa ehleliwe bese beshintshela ekuqapheni noma ekwelashweni okuhlukile.
Kufanele uxoxe nganoma yimaphi amavithamini noma izithasiselo nethimba lakho le-oncology ngaphambi kokuwathatha ngesikhathi sokwelashwa nge-bevacizumab-awwb. Ezinye izithasiselo zingase zihlangane nokwelashwa kwakho umdlavuza noma zithinte ukuthi kusebenza kahle kangakanani.
Ezinye izithasiselo, ikakhulukazi lezo ezithinta ukujiya kwegazi noma umfutho wegazi, kungenzeka zingaphephile ukuzithatha nge-bevacizumab-awwb. Udokotela wakho angakuncoma ukuthi yiziphi izithasiselo eziphephile futhi eziwusizo esimweni sakho.
Abantu abaningi bathola ukuthi i-multivitamin eyisisekelo iyasiza ngesikhathi sokwelashwa komdlavuza, kodwa ngaso sonke isikhathi kungcono ukuthola imvume kadokotela wakho kuqala. Bangakuncoma izithasiselo ezithile ezingasiza ukusekela impilo yakho ngesikhathi sokwelashwa.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.